CB
PVLA

Commerce Bank’s Palvella Therapeutics PVLA Stock Holding History

Commerce Bank’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-250
Closed -$3.66K – 1231
2024
Q1 		$3.66K Hold
250
– – ﹤0.01% 1194
2023
Q4 		$3.64K Hold
250
– – ﹤0.01% 1179
2023
Q3 		$5.96K Hold
250
– – ﹤0.01% 1144
2023
Q2 		$3.31K Hold
250
– – ﹤0.01% 1156
2023
Q1 		$19.5K Hold
250
– – ﹤0.01% 1159
2022
Q4 		$20.8K Hold
250
– – ﹤0.01% 1123
2022
Q3 		$23K Hold
250
– – ﹤0.01% 1132
2022
Q2 		$37K Hold
250
– – ﹤0.01% 1133
2022
Q1 		$61K Buy
+250
New +$65.7K ﹤0.01% 1164

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Commerce Bank's PVLA Position: Q2 2024 in Review

Commerce Bank sold out of Palvella Therapeutics (PVLA) in Q2 2024, closing a stake of 250 shares — an estimated $3.66K sold.

Commerce Bank first reported a position in PVLA in Q1 2022 and held it in 9 quarters. The position peaked at $61K in Q1 2022. 21 funds tracked by Wall St. Rank hold PVLA as of Q2 2024.

  • Commerce Bank reported no remaining Palvella Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Commerce Bank sold 250 Palvella Therapeutics shares in Q2 2024, an estimated $3.66K.
  • Commerce Bank first reported a position in Palvella Therapeutics in Q1 2022 and held it in 9 quarters.
  • Commerce Bank's Palvella Therapeutics position peaked at $61K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2024.

Based on Commerce Bank's 13F filing for Q2 2024, filed 12 Aug 2024.